Roche

News

First patient gets bowel cancer jab in NHS 'matchmaker' push

The first patient has received a personalised colorectal cancer vaccine, produced by BioNTech, as part of NHS England and Genomics England’s Cancer Vaccine Launch Pad (CVL

News

Roche trumpets potential ‘best-in-class’ obesity drug

Roche has reported early clinical data with its candidate obesity therapy CT-388, bought as part of its $3.1 billion takeover of Carmot Therapeutics that was announced las

News

FDA clears Roche self-collection system for HPV screening

The US FDA has approved a human papillomavirus (HPV) self-sampling solution developed by Roche that allows patients to collect a sample themselves in a healthcare setting.

News

Roche says it has shed 20% of NMEs from its pipeline

Roche chief executive Thomas Schinecker said today that one in five of the pharma division’s pipel

News

FDA clears Roche’s Alecensa for adjuvant use in NSCLC

Roche has broken new ground with its ALK inhibitor Alecenesa, becoming the first drug in the class to be approved by the FDA for adjuvant use after surgery in early-stage,

News

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting

First patient gets bowel cancer jab in NHS 'matchmaker' push

Roche trumpets potential ‘best-in-class’ obesity drug

FDA clears Roche self-collection system for HPV screening

Roche says it has shed 20% of NMEs from its pipeline

FDA clears Roche’s Alecensa for adjuvant use in NSCLC

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks